Related Experiment Video
Updated: Jul 4, 2026

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
Published on: May 26, 2023
Pediatric heart failure
F M Picchio1, R Formigari, A Balducci
1Cardiovascular Department, Pediatric Cardiology and Adult Congenital Unit, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy. fernando.picchio@unibo.it
Insights
Pediatric heart failure, often caused by congenital heart defects, differs from adult forms. Treatment includes medications, devices, and in severe cases, cardiac transplantation for improved survival.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Medicine
- Clinical Pediatrics
Background:
- Heart failure presents unique challenges in pediatric patients compared to adults.
- Congenital heart defects are the predominant cause of heart failure in children.
- Infants and young children exhibit distinct clinical presentations of heart failure.
Purpose of the Study:
- To review the current understanding of pediatric heart failure.
- To outline the diagnostic and therapeutic approaches for heart failure in children.
- To highlight the differences and similarities between pediatric and adult heart failure.
Main Methods:
- Review of existing literature and clinical guidelines on pediatric heart failure.
- Analysis of etiological factors, clinical manifestations, and treatment strategies.
- Synthesis of data from adult trials extrapolated to pediatric populations.
Main Results:
- Congenital heart defects are the primary etiology, often involving volume/pressure overload.
- Myocardial contractile dysfunction is less common but recognized.
- Established medical therapies include diuretics, ACE inhibitors, beta-blockers, and digitalis.
- Emerging treatments include new inotropes, non-pharmacological interventions, and mechanical support.
- Cardiac transplantation offers a viable option for end-stage pediatric heart failure.
Conclusions:
- Pediatric heart failure requires tailored management strategies distinct from adult care.
- A multi-faceted approach involving medical, interventional, and surgical options is crucial.
- Continued research in pediatric cardiac pharmacology is needed to optimize treatment outcomes.
Abstract:
Heart failure is a clinical syndrome which presents similarities and differences between children and adults; in pediatric age the spectrum of causes of heart failure is wide and congenital heart defects are the most common etiology. Volume and pressure overload on a ''normal myocardium'' is the classical physiological pattern while myocardial contractile dysfunction of different etiology is much less observed in the pediatric population. However there are some peculiarities in clinical presentation of heart failure in infants and small children. The medical therapy cornerstones still remain loop diuretics, angiotensin-converting enzyme inhibitors, beta-blockers and digitalis. There are also some reported experiences with new inotropics drugs in acute heart failure. In pediatric cardiology there are few prospective studies on pharmacology of heart failure and the data are often extrapolated from adult large trials. Non pharmacological treatment with autonomic implantable cardioverter defibrillators and resynchronization therapy as well as the surgically implant of ventricular assist devices are increasingly employed in children. Cardiac transplantation is currently the treatment option with good outcome and long-term survival in pediatric patients with end-stage or refractory heart failure.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure V: Medical Management
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
